Thomas O Cameron (Tom Cameron)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 2

Top Topics

Tyrosine Kinase

Acute Lymphoblastic Leukemia

Top Venues

Science signaling

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Scott M Wemlinger, Chelsea R Parker Harp, Bo Yu, Ian R Hardy, Matthew Seefeldt, Jennifer Matsuda, Michael Mingueneau, Kerri A Spilker, Thomas O Cameron, James W Larrick, Andrew Getahun, John C Cambier
Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model. Journal of immunology (Baltimore, Md. : 1950) 208 (7) (2022)
Kate L Henry, Debra Kellner, Bekim Bajrami, John E Anderson, Mercedes Beyna, Govinda Bhisetti, Thomas O Cameron, Andrew G Capacci, Andrea Bertolotti-Ciarlet, Jun Feng, Benbo Gao, Brian Hopkins, Tracy Jenkins, Kejie Li, Tricia May-Dracka, Paramasivam Murugan, Ru Wei, Weike Zeng, Norm Allaire, Alan Buckler, Christine Loh, Peter Juhasz, Brian Lucas, Katelin A Ennis, Elisabeth Vollman, Ellen Cahir-McFarland, Erik C Hett, Michelle L Ols
CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling. Science signaling 11 (541) (2018)